NCT01068483View on ClinicalTrials.gov

Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2011

Study Completion Date

August 31, 2012

Conditions
Breast CancerColon CancerOvarian CancerEndometrium Cancer
Interventions
DRUG

BKM120

Trial Locations (5)

37203

Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4), Nashville

M5G 2M9

Novartis Investigative Site, Toronto

3015 CE

Novartis Investigative Site, Rotterdam

3075 EA

Novartis Investigative Site, Rotterdam

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY